Search by Drug Name or NDC
NDC 68382-0189-05 Dipyridamole 75 mg/1 Details
Dipyridamole 75 mg/1
Dipyridamole is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Zydus Pharmaceuticals USA Inc.. The primary component is DIPYRIDAMOLE.
MedlinePlus Drug Summary
Dipyridamole is used with other drugs to reduce the risk of blood clots after heart valve replacement. It works by preventing excessive blood clotting.
Related Packages: 68382-0189-05Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Dipyridamole
Product Information
| NDC | 68382-0189 |
|---|---|
| Product ID | 68382-189_8b638b19-214a-4a58-a336-656d690130e3 |
| Associated GPIs | 85150030000330 |
| GCN Sequence Number | 041700 |
| GCN Sequence Number Description | dipyridamole TABLET 75 MG ORAL |
| HIC3 | M9P |
| HIC3 Description | PLATELET AGGREGATION INHIBITORS |
| GCN | 53143 |
| HICL Sequence Number | 000168 |
| HICL Sequence Number Description | DIPYRIDAMOLE |
| Brand/Generic | Generic |
| Proprietary Name | Dipyridamole |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Dipyridamole |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET, FILM COATED |
| Route | ORAL |
| Active Ingredient Strength | 75 |
| Active Ingredient Units | mg/1 |
| Substance Name | DIPYRIDAMOLE |
| Labeler Name | Zydus Pharmaceuticals USA Inc. |
| Pharmaceutical Class | Decreased Platelet Aggregation [PE], Platelet Aggregation Inhibitor [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA040874 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 68382-0189-05 (68382018905)
| NDC Package Code | 68382-189-05 |
|---|---|
| Billing NDC | 68382018905 |
| Package | 500 TABLET, FILM COATED in 1 BOTTLE (68382-189-05) |
| Marketing Start Date | 2008-05-22 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |